Qin Han

Dr. Qin Han

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
Hayson WangHayson Wang
Hayson Wang
ESElliot Tianyu Sun
Elliot Tianyu Sun
CZChunhua Zhao
Chunhua Zhao
BCBo Chen
Bo Chen
QHQin Han
Qin Han
XWXiaojun Wang
Xiaojun Wang
Background: Although autologous fat grafting is a feasible surgical technique to improve facial deformity in patients with localized scleroderma, its success is limited by the low graft retention induced by the local inflammatory environment. This study investigated the potential effect of adipose-derived stem cells (ASCs) on skin fibrosis and fat retention in a localized scleroderma mouse model. Methods: BALB/C nude mice that were induced by bleomycin to establish a localized scleroderma model were divided randomly into five groups: blank control; fat grafting; and low, moderate, and high doses of ASC-assisted fat grafting. The backs of the mice were subcutaneously injected with phosphate-buffered saline or fat, or fat with low, moderate, and high doses of ASCs (1 × 105/mL, 5 × 105/mL, and 25 × 105/mL, respectively). The skin fibrosis and fat retention were analyzed after 1 month or 3 months, respectively. Results: Compared to the disease model group, the fat-grafting group, and the low- and moderate-dose ASC-enriched groups, the high-dose ASCs significantly attenuated skin fibrosis, inhibited the production of type III collagen and transforming growth factor-β1, increased fat graft retention, enhanced the expression of angiogenesis-related cytokines and angiogenesis, and increased the expression of adipogenesis-related cytokines. Conclusions: The results demonstrated that high-dose ASCs attenuated skin fibrosis and improved fat retention in a localized scleroderma model by reducing inflammation and by promoting angiogenesis and adipogenesis. The authors further demonstrated that ASCs enhanced adipogenesis through the AKT/ERK signaling pathway. Clinical Relevance Statement: Fat grafting has been used to treat localized scleroderma patients but with low fat retention. In this study, ASC attenuated skin fibrosis and improved fat retention in the localized scleroderma model, providing evidence for cell therapy in future application of localized scleroderma treatment.

13 May 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
QHQin Han
Qin Han
ZWZhangxin Wu
Zhangxin Wu
HGHongyan Guo
Hongyan Guo
XZXue Zhang
Xue Zhang

7 May 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
QHQin Han
Qin Han
HGHongyan Guo
Hongyan Guo
ZWZhangxin Wu
Zhangxin Wu
JSJiaxin Shi
Jiaxin Shi
XZXue Zhang
Xue Zhang
Persistent HPV infections may cause cervical and vaginal intraepithelial neoplasia (CIN and VaIN). Traditional methods might destroy the structure and function of the cervix. 5-aminolevulinic acid photodynamic therapy (ALA-PDT) is a non-invasive targeted therapy. This study aims to evaluate the efficacy and safety of ALA-PDT for CIN and VaIN and the clearance of HPV. A retrospective study of 303 patients who confirmed CIN or VaIN and received ALA-PDT was conducted. All the patients were followed up at six and twelve months after treatment and then annually thereafter. The effect was evaluated through HPV genotyping, a cytology test, and colposcopy-directed biopsy if necessary. After ALA-PDT, the remission rates for CIN 2, CIN 3, VaIN 2, and VaIN 3 were 90.6%, 88.5%, 87.3%, and 77.8%. For CIN 1, the remission rate at the six-month follow-up was 93.1%. The total HPV clearance rates were 72.5% at the six-month follow-up and 85.7% at the 12-month follow-up. The most common adverse event was vaginal discharge. No severe adverse effect was observed. ALA-PDT is an effective and safe treatment for all grades of CIN and VaIN and is helpful in clearing HPV with minimal side effects. This treatment may not influence fertility and delivery.

1 September 2015 in Journal of Nanoscience and Nanotechnology
Verified
Journal Article
Closed access
SHShanshan Hu
Shanshan Hu
YZYongxiang Zeng
Yongxiang Zeng
SYShuying (Sheri) Yang
Shuying (Sheri) Yang
QHQin Han
Qin Han
HCHe Cai
He Cai
JWJian Wang
Jian Wang
The past several years have witnessed significant advances in stem cell therapy, tissue engineering and regenerative medicine. Graphene, with its unique properties such as high electrical conductivity, elasticity and good molecule absorption, have potential for creating the next generation of biomaterials. This review summarizes the interrelationship between graphene and stem cells. The analysis of graphene when applied on mesenchymal stem cells, neural stem cells, induced pluripotent stem cells, embryonic stem cells, periodontal ligament stem cells, human adipose-derived stem cells and cancer stem cells, and how graphene influences cell behavior and differentiation are discussed in details.

7 April 2025 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
QHQin Han
Qin Han
TWTongxia Wang
Tongxia Wang
ZWZhangxin Wu
Zhangxin Wu
JSJiaxin Shi
Jiaxin Shi
XZXue Zhang
Xue Zhang
HGHongyan Guo
Hongyan Guo
Cervical intraepithelial neoplasia grade 3(CIN 3) is a precancerous lesion condition with high progression rate and is advised to be treated immediately. Because traditional treatments have limited effects or complications, here we evaluated the efficacy and safety of topical 5-aminolevulinic acid (ALA)-based photodynamic therapy (PDT). This study consisted of 56 female patients diagnosed with CIN3. A 20 % 5-ALA jelly formation was topically applied to the cervix, followed by 635 nm PDT at 7-14 days intervals. Cytology, human papillomavirus (HPV) genotyping, colposcopy, and pathology were assessed after treatment. Among the 56 patients in our study, 26.8 % (15/56) patients had disease remission after just one course PDT, 69.6 % (39/56) patients had partial remission to CIN2, which suggested a response to the therapy and should be treated with more course. The total pathological regression rate was 89.3 %(50/56). Although6 patients did CKC finally, none of the pathology suggest cervical cancer and 2 of them were LSIL. The HPV clearance rate during the 6-month follow-up was 51.8 %. 4 patients had recurrent disease during the 2-year follow-up time point. The most common adverse event was increased vaginal discharge, other side effects include abdominal pain, vulvar pruritus, and vaginal bleeding. No severe adverse effect was observed during the treatment. ALA-PDT is a treatment option for CIN 3 which meet certain conditions, with the main goal to preserve the struction and founction of cervix.

22 March 2021 in Research Square
Verified
Preprint
Open access
PDF file
QHQin Han
Qin Han
HGHongyan Guo
Hongyan Guo
BackgroundSmall-cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare but highly undifferentiated, aggressive malignancy that primarily affects young women. Due to the early onset, unclear familial history, and vague presenting symptoms, most SCCOHT patients present with advanced disease and have a very poor prognosis. Although several therapeutic regimens have been proposed, there is no consensus on the optimal strategy. Case presentationWe described three cases of advanced-stage SCCOHT treated with cytoreductive surgery and chemotherapy with or without immune checkpoint blockade treatment. The patients showed different survival rates.ConclusionsGiven the almost universal mortality of advanced SCCOHT during long-term follow-up, we believe these cases highlight the importance of prompt diagnosis as well as early, aggressive, and combined modality treatment of SCCOHT. We also believe that improved therapies could result in more young patients surviving SCCOHT.